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Abstract
Background: Programmed Death-1 (PD-1; CD279) receptor molecule is widely believed to be a negative regulator
predominantly expressed by exhausted/activated mouse T cells. Upon interaction with its ligands, PD-L1 and PD-L2, PD-1
inhibits activation of T cells and cytokine production, which has been documented in various viral and fungal infections as
well as in vitro studies. Therefore, inhibition of T cell responses by PD-1 resulted in disease resistance in a variety of mouse
infection models studied heretofore.
Methodology/Principal Findings: Here, we report that PD-1 deficient (PD-1
2/2) mice infected with Mycobacterium
tuberculosis (M. tb) H37Rv by the aerosol route have increased susceptibility as compared with their wild type littermates.
Surprisingly, M. tb antigen-specific T cell proliferation was dramatically reduced in PD-1 deficient animals compared with
wild-type littermates, and this was due to increased numbers of regulatory T cells (Tregs) and recruitment of mesenchymal
stem cells. Furthermore, PD-1
2/2 mice exhibited decreases in the autophagy-induced LC3-B marker protein in
macrophages.
Conclusions/Significance: Our findings suggest that PD-1 does not play an inhibitory role during M. tb infection and instead
promotes mycobacterial clearance in mice.
Citation: Tousif S, Singh Y, Prasad DVR, Sharma P, Kaer LV, et al. (2011) T Cells from Programmed Death-1 Deficient Mice Respond Poorly to Mycobacterium
tuberculosis Infection. PLoS ONE 6(5): e19864. doi:10.1371/journal.pone.0019864
Editor: Shabaana Khader, University of Pittsburgh, United States of America
Received February 3, 2011; Accepted April 12, 2011; Published May 12, 2011
Copyright:  2011 Tousif et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research work was supported by Grant WT01/GD/09/339 from the Wellcome Trust and Department of Biotechnology (DBT) Alliance (http://www.
wellcomedbt.org) and DB/03/GD/08/306 from DBT (http://dbtindia.nic.in/index.asp), Government of India. ST is supported by a DBT grant and YS is supported by
a Wellcome-DBT grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: dasgo@icgeb.res.in
. These authors contributed equally to this work.
Introduction
Mycobacterium tuberculosis (M. tb) infection is a global health
problem with an estimated one third of the global population
latently infected, and two million deaths annually [1,2]. Co-
infection with human immunodeficiency virus (HIV) dramatically
enhances the risk of mortality and poses the threat of a pandemic
in this modern era [3,4]. Cellular immune responses, which are
mediated by IFN-c, play a central role in protective immunity
against M. tb [5,6]. Therefore, animals that are impaired in
mounting T helper (Th) 1 responses or IFN-c signalling exhibit
dramatic susceptibility to M. tb infection [7,8,9]. On the other
hand, Th2 responses exacerbate M. tb infection [10,11]. Likewise,
regulatory T cells (Tregs) have been shown to assist disease
progression by inhibiting protective immune responses [12,13].
Recently, we have shown that M. tb recruits mesenchymal stem
cells (MSCs) to granulomas to promote persistent infection and
Treg expansion in infected mice [14]. The role of Th17 cells in M.
tb is not entirely clear, however, some reports have suggested a role
of IL-17 in host resistance against M. tb and granuloma formation
[15]. Therefore, a delicate balance between Th1, Th2, Th17, and
Treg cells determines the disease outcome in M. tb infections.
A relatively newly discovered co-stimulatory receptor, Pro-
grammed Death-1 (PD-1; CD279), is a member of the CD28
family of co-stimulatory molecules, expressed by activated T, B
and mesenchymal stem cells [16,17,18,19], and binds with its
ligands programmed death ligand 1 and 2 (PD-L1 and PD-L2; B7-
H1 and B7-DC) expressed on antigen-presenting cells (APCs)
[16,18,20,21] and other cells. Engagement of PD-1 with its ligands
has been shown to induce exhaustion in T cells, and thereby to
inhibit T cell responses [22]. A number of infection studies with
viral and fungal pathogens reported that PD-1/PD-L interactions
inhibit T and B cell proliferation [23,24,25,26,27], and inhibition
of such interactions dramatically rescues T cell functions and host
resistance to infection [28]. However, some studies revealed that
the PD-1/PD-L2 (B7-DC) interaction can drive the proliferation
of CD4
+ and CD8
+ T cells [29]. Unlike viral and fungal infections,
Leishmania mexicana infection in PD-L2
2/2 mice resulted in
exacerbated disease with no Th1/Th2 cytokine skewing, whereas
PD-L1
2/2 mice exhibited reduced IL-4 production and protec-
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PD-L interactions inhibit M. tb antigen-specific peripheral T cells
[31].
The divergent roles of CD4
+ T cells (IFN-c-producing Th1 cells
and IL-4- and IL-13-producing Th2 cells) in manipulating the
macrophage’s phagocytic activity to control M. tb infection by
activating and repressing autophagy, respectively, have been
investigated [11,32]. Historically, it has been known that M. tb
resides in phagosomes and survives by interfering with phagolyso-
some biogenesis within macrophages or dendritic cells [33,34].
Autophagy has a diverse role in several pathologies to protect the
host against infections, cancer and aging [35]. The identification of
signals that regulate autophagy and genes that execute autophagy
has assisted in the development of reagents to manipulate the
autophagy pathway. Activation of mammalian autophagy factor
LC3 during autophagy results in a non-soluble form called LC3-II
(also called LC3-B or Atg8) that stably associates with the
autophagosomal membrane [36]. Autophagy can be induced by
rapamycin, which can result into colocalization of the mycobac-
terial phagosome with the autophagy factor LC3, and induction of
autophagy and suppression of intracellular survival of bacteria
[34,37,38].
Here we report that PD-1 deficient (PD-1
2/2) animals infected
with M. tb exhibit higher susceptibility when compared to their
wild type littermates. Consistently, the number of responding
activated CD4
+ memory T cells was dramatically lower in lung
and spleen of PD-1
2/2 animals. Furthermore, production of T
cell-derived cytokines was significantly higher in PD-1
2/2
animals. In addition to this, PD-1
2/2 mice recruited more MSCs
and Tregs to the site of infection as compared with WT
littermates. Furthermore, macrophages from these animals
expressed lower levels of the autophagy marker LC3-B. Taken
together, these observations suggest that, unlike most other
infections, PD-1 plays an important role in culminating host
resistance in M. tb infection.
Results
M. tb H37Rv augments PD-1 expression in WT mice and
enhances bacterial burden in PD-1
2/2 mice
It is well established that PD-1 is expressed on activated/
exhausted T cells and inhibits T cell responses. Interestingly, the
amount of PD-1 expression and its engagement with ligands (PD-
L1 and PD-L2) decides the threshold for T cell inactivation and
the amount of cytokine production [39,40,41]. A study with
human subjects indicated that substantial numbers of peripheral T
cells express PD-1 in tuberculosis (TB) patients [31], and the
inhibition of PD-1 resulted in higher M. tb antigen-specific
proliferation in vitro. Therefore, we examined the expression of
PD-1 on T cells from M. tb infected wild type C57BL/6 mice. It
was found that both CD4
+ and CD8
+ T cells significantly
upregulated expression of PD-1 when compared with uninfected
littermates (Fig. 1A). Absolute numbers of CD4
+ and CD8
+
splenocytes in infected WT mice also showed significant
differences in PD-1 expression compared with control mice
(Fig. 1B). Therefore, to investigate the role of PD-1 in M. tb
infection, we infected PD-1
2/2 mice and determined bacterial
burden in different organs. Consistently, lung tissue histology
revealed that PD-1
2/2 mice had very large and immature
granulomas (Fig. 1C). Furthermore, PD-1
2/2 mice have deformed
and perforated lungs (gross morphology) compared to WT after
M. tb infections (Fig. 1D). Unexpectedly and paradoxically,
infected PD-1
2/2 mice had higher bacterial load in spleen and
lungs compared to infected wild type littermates (Fig. 1E).
Therefore, unlike viral and fungal infections, the absence of PD-
1 promotes susceptibility to M. tb infection.
M. tb infected PD-1
2/2 mice exhibit dramatically lower
antigen-specific immune responses
The higher bacterial burden in PD-1
2/2 mice prompted us to
investigate the M. tb antigen-specific immune responses in these
animals. We examined proliferation of splenocytes and lung cells
induced by M. tb complete soluble antigen (CSA) at day 30 after
infection. Surprisingly, cells from PD-1
2/2 animals exhibited
notably reduced proliferation throughout disease progression in
both lung and spleen (Fig. 2A and B). However, control uninfected
PD-1
2/2 mice did not exhibit any significant difference in T cell
proliferation compared with wild type littermates in response to M.
tb lysate protein stimulation (Fig. 2). This observation suggested
that there is a defect in T cell activation in PD-1
2/2 mice. Next,
we tested whether there is any defect in B cell activation in these
animals. To do so, we performed B cell proliferation assays in the
presence of the B cell mitogen LPS. Indeed, we observed that B
cell proliferation was also abnormal in infected PD-1
2/2 animals
compared to WT mice (Fig. 2C). An earlier time point at 15 days
provided similar findings (data now shown). To provide insight
into the mechanism of such unexpected findings, we examined the
number of activated T cells in M. tb infected splenocytes. We
observed that PD-1
2/2 animals contained significantly lower
numbers of CD44-positive (infected PD-1
2/2, 30.9619.6%
[mean6STDEV] versus infected WT, 39.5623.3%; n=9,
p=0.0003) and CD25-positive (14.666.9% versus 22.5611.0%;
n=9, p=0.007) CD4
+ T cells when compared with their wild type
littermates in spleen (Fig. 3A, C). Similarly, in lungs, CD4
+ T cells
also showed down regulation of CD25 (5.962.1% versus
9.263.3%; n=9, p=0.05) expression in PD-1
2/2 mice. The
expression of CD44 was reduced in lungs of PD-1
2/2 compared
Figure 1. M. tb H37Rv augments PD-1 expression in WT mice and enhances bacterial burden in PD-1
2/2 mice compared to WT mice.
Total splenocytes from WT mice infected with H37Rv were stained with anti-CD4, anti-CD8 and anti-PD-1 using fluorescently-labelled antibodies to
determine the expression of PD-1 on T cell subsets by flow cytometry. A. PD-1 expression on CD4 and CD8 cells of infected and uninfected WT mice.
Cells were gated on CD4
+ and CD8
+ T cells and analyzed for the % of cells expressing PD-1 on the gated population. The upper dot plots (top panels)
show PD-1 expression for CD4 cells, and the lower dot plots (bottom panels) show PD-1 expression for CD8 cells. Data shown here is a representative
experiment of three. B. Total PD-1 costimulatory molecule expression by CD4
+ and CD8
+ splenocytes (mean6STDEV) in uninfected and infected WT
mice. PD-1 expression is significantly higher in both CD4
+ (p=0.01) and CD8
+ (p=0.03) splenocytes, as determined by two-tailed student’s t test.
Data shown here is a representative experiment of three. C. Gross pathology photographs of the lungs from infected WT and PD-1
2/2 mice. PD-1
2/2
mice have very distinct deformed and perforated lungs after M. tb infection. It appears that PD-1
2/2 mice develops cavities in the lungs, which is very
unique to these mice compared to WT mice. D. Histology of the lung tissue sections after 30 days of infection in WT and PD-1
2/2 mice stained with
both Haematoxylin & Eosin and Acid Fast dyes. WT mice show very well structured granulomas compared to PD-1
2/2 mice, whereas PD-1
2/2 mice
had very large granulomas with perforated lungs (26larger in size as shown in the figure). PD-1
2/2 mice developed severe lesions in the lungs after
30 days of infection with H37Rv. E. Bacterial burden is significantly higher at day 75 in PD-1
2/2 mice compared to WT in both spleen (p=0.0001) and
lungs (p=0.03). Data shown here is a representative of two independent experiments. Each CFU experiment has been carried out in triplicates (3
mice per experiment).
doi:10.1371/journal.pone.0019864.g001
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(Fig. 3B). CD25 is a marker for activated T cells as well as
regulatory CD4
+ T cells (Tregs). Therefore, we determined
expression of Foxp3, a Treg specific fork-head box transcription
factor, among CD25
+ T cells in M. tb infected PD-1
2/2 and wild
type animals, using a Foxp3 reporter system. Tregs increased both
in lungs and spleens of PD-1
2/2 mice (Fig. 4A, B). Therefore, the
differences in the proliferation were likely due to the expansion of
Tregs during the progression of disease. Similarly, CD25
expression was determined on CD8
+ T cells, but we could not
detect any difference (data not shown) between WT and PD-1
2/2
mice. Furthermore, we found that PD-1
2/2 mice recruited more
MSCs to spleens compared to WT animals (Fig. 4C). Therefore,
these data suggested that the numbers of T cells responding to M.
tb antigens are reduced due to increased numbers of Tregs and
MSCs in PD-1
2/2 mice.
Figure 2. Reduced T and B cell proliferation in response to M. tb bacterial protein lysate (CSA) or LPS in PD-1
2/2 mice. To rB
lymphocytes were isolated from spleens and lung tissues from uninfected mice and mice infected with H37Rv. T and B cell proliferation assays were
performed using tritiated thymidine. A. In vitro T cell proliferation of splenocytes from infected and uninfected PD-1
2/2 mice at day 30 after infection
compared to WT mice, after stimulation with M. tb H37Rv protein lysate. Data shown here is representative of three independent experiments with
three mice in each group and represents the mean6STDEV values. B. In vitro proliferation of lung T cells of infected and uninfected PD-1
2/2 mice at
day 30 of infection compared to WT mice after stimulation with M. tb H37Rv protein lysate. Data shown here is representative of three independent
experiments with three mice in each group. Each value in bar diagram is mean6STDEV of triplicate results. C. In vitro proliferation of splenic B cells of
infected or uninfected PD-1
2/2 mice at day 30 compared to WT mice after stimulation with varying concentrations of LPS. Data shown here is
representative of three independent experiments (mean6STDEV) with three mice in each group.
doi:10.1371/journal.pone.0019864.g002
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2/2
animals
In the previous section, we found that PD-1
2/2 animals
induced lower M. tb antigen-specific T cell proliferative responses.
Therefore, to examine whether antigen-specific responses exhib-
ited a bias towards specific T helper cell subsets, we determined
cytokines in the culture supernatant. We observed that PD-1
2/2
animals produced almost equal amount of cytokines irrespective of
their association with the Th1, Th2, or Th17 phenotype after
twenty four hours of antigen stimulation. However, when we
determined the cytokines after 48 and 72 hours of antigen
stimulation, we found an increase in cytokines in PD-1
2/2 mice
Figure 3. Diminished expression of CD44 by splenic CD4 and CD8 T cells. Splenocytes and lung cells from WT and PD-1
2/2 mice infected
with H37Rv were stained with anti-CD4, anti-CD8, anti-CD44 and anti-CD25 antibodies and data were acquired by flow cytometry. CD4
+ and CD8
+ T
cells were gated against CD44. A. Reduced CD44 expression by splenic CD4 and CD8 T cells. The percentage of cells expressing CD44 among CD4
+
and CD8
+ T cells is shown in the bar diagram with mean6STDEV and t-test. Data shown here are representative of nine mice per group. B. CD44
expression by lung CD4 and CD8 T cells. The percentage of cells expressing CD44 among CD4
+ and CD8
+ T cells is shown in the bar diagram with
mean6STDEV and t-test. Data shown here are representative of nine mice per group. C. CD25 expression on splenic and lung T cells. Data shown
here are representative of nine mice per group. The bar diagram shows mean6STDEV value with student’s t-test.
doi:10.1371/journal.pone.0019864.g003
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2/2Foxp3
gfp mice following M. tb infection. Cells isolated from both lung tissues and spleens of
H37Rv-infected WT Foxp3
gfp and PD-1
2/2Foxp3
gfp mice were stained with anti-CD4 and anti-CD25 antibodies at 30 days after infection and analyzed by flow
cytometry. A. Total numbers of Tregs in infected WT (Foxp3
gfp)a n dP D - 1
2/2 (Foxp3
gfp)m i c e .P D - 1
2/2 mice have a two-fold increase in natural Tregs after 30
days of infection. GFP
+ cells show the Treg cell population. B. Both lungs and spleen have increased numbers of Tregs at 30 days after infection. Total CD4
+ T
cells weregatedandthen expression of CD25andFoxp3-(GFP) was analysed.C.Recruitment of mesenchymalstemcells (MSCs)in spleens of WT and PD-1
2/2
mice. Cells were gated on CD3
2CD19
2SCA-1
+ cells for analysis of MSCs. PD-1
2/2 mice have a three-fold increasei nM S C sc o m p a r e dt oW Tm i c e .
doi:10.1371/journal.pone.0019864.g004
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2/2
mice compared to WT mice (Fig. 5C). This observation suggested
that M. tb antigen responding T cells in PD-1
2/2 mice acquired
an anergic phenotype, but that activation of neighbouring T cells
resulted in cytokine production that overcame their anergic
status. Therefore, we tested the response of spleen cells in the
presence of IL-2. Supplementation of IL-2 had no effect on the
proliferative responses in these animals (data not shown). Thus,
we tested cytokines by intracellular cytokine staining. Surprising-
ly, we found that cytokines were produced by non-proliferating
cells in both lungs and spleens of PD-1
2/2 animals. Furthermore,
intracellular cytokine staining revealed a significant increase in
IL-17-producing cells in lungs whereas alterations in IL-4 and
IFN-c were not significant (Fig. 6A and B). In the case of spleen,
there was a similar trend for IL-17 and IFN-c, and IL-4 was
found to be significantly increased as well (Fig. 6A and B). This
observation suggested that M. tb antigen-specific T cells from
PD-1
2/2 animals may be defective in cellular proliferation.
Furthermore, because of their inability to proliferate, we postulate
that the capacity of these cells to consume cytokines is reduced,
which results in the observed elevation of cytokines at late time
points of antigen stimulation.
M. tb infected PD-1
2/2 macrophages do not undergo
autophagy
In macrophages and DCs, it has been shown that autophagy and
defence against intracellular pathogens via immunity-related
GTPase Irgm1 (LRG-47) has a protective role against M. tb,
resulting in clearance of the M. tb organisms from macrophages
[37]. We have seen very minor differences in LC3-B expression in
DCs of infected lungs of WT and PD-1
2/2 mice. However, in
infected PD-1
2/2 mice CD11b
+ and CD11c
+ cells had strikingly
lowerLC3-B expression compared with WT mice (Fig. 7).PD-1
2/2
mice have very low autophagy and, therefore, we speculate that due
to this defect these mice probably are unable to clear bacteria from
the peritoneal macrophages. Nonetheless, autophagy plays a
significant role in the response of PD-1
2/2 mice to M. tb infection.
Discussion
The PD-1/PD-L pathway has been extensively studied in
various infection models. However, in the case of M. tb this
pathway is still under exploration. Recently, it has been shown that
PD-1
2/2 mice have higher mycobacterial burden compared to
WT infected mice and have higher serum cytokines [42,43], and
we have confirmed those findings here. When PD-1 binds to PD-
L, T cells become exhausted and thereby inhibit T cell responses
[22]. Various studies with viral and fungal infections reported that
PD-1/PD-L interactions inhibit T and B cell proliferation
[23,24,25,26,27], and inhibition of such interactions dramatically
rescues T cell functions and acquired host resistance [28].
However, some studies revealed that PD-1/PD-L2 (B7-DC)
interaction drives the proliferation of CD4
+ and CD8
+ T cells
[29]. To delineate the mechanism of PD-1/PD-L action during M.
tb infection, we have performed T and B cell proliferation assays
and surprisingly, we found that PD-1
2/2 mice after M. tb infection
exhibit defective proliferation of lymphocytes both in lungs and
spleen. Studies investigating the role of PD-1 and its ligands PD-L1
and PD-L2 in patients infected with M. tb suggested that blockade
of this pathway enhances IFN-c production by CD3
+ T
lymphocytes and additionaly showed that T cells also express
PD-L2 [31]. Unlike these human studies, we did not observe any
increase in IFN-c production in PD-1
2/2 mice compared to WT
mice; however, we did observe reduced proliferation of T
lymphocytes from PD-1
2/2 mice. It has been shown that, in the
absence of PD-1 in the mouse model of TB infection, PD-L1 binds
to B7-1 molecules, which inhibits T cell proliferation and cytokine
regulation [44], a finding that further support our observations in
PD-1
2/2 mice. Therefore, our data strengthen the idea of
bidirectional inhibitory interactions between B7-1 and PD-L1 in
the absence of PD-1 molecules.
It is well known that natural regulatory T cells help in disease
progression of M. tb infection by inhibiting protective immune
responses [12,13]. We have also found that PD-1
2/2Foxp3
gfp
mice have higher numbers of natural Tregs compared to WT
mice. It appears that M. tb recruits Treg cells to the site of
infection, which is further assisted by MSCs [14]. MSCs dampen
the immune response by inhibiting T cell proliferation.
A recent report also suggested that CD4
+ T cells promote rather
than inhibit the bacterial burden in PD-1-deficient mice [42]. In
agreement with this report, we suggest that MSCs have an
important role in the susceptibility of PD-1
2/2 mice to M. tb
infection. Furthermore, IFN-c, which plays a central role in
protective immunity against M. tb [5,6], was found to be very
similar in WT and PD-1
2/2 mice using intracellular staining, but
our PD-1
2/2 serum data suggested that these mice have abundant
amounts of accumulated IFN-c. Therefore, PD-1
2/2 animals,
which are impaired in mounting Th1 responses or in producing
IFN-c, are susceptible to M. tb infection. On the other hand, Th2
responses, which exacerbate M. tb infections [10,11], were found
to be increased in PD-1
2/2 animals, suggesting that these mice
exhibit a severe imbalance in cytokine regulatory mechanisms due
to loss of PD-1. PD-1
2/2 mice also produce increased levels of
inflammatory cytokines such IL-17, which should be protective,
yet due to the concomitant increase in IL-4 production, these mice
are unable to control the bacterial burden.
Our findings that macrophages from PD-1-deficient exhibit
reduced autophagy suggested that these cells are unable to
generate phagolysosomes to kill the engulfed bacteria [34]. Thus,
overall this report suggests that PD-1-deficient mice have a defect
in T cell proliferation and phagolysosomal formation. Therefore,
our study provides a mechanistic link between autophagy and co-
stimulatory pathways, which may be involved in higher M. tb
bacterial growth and disease progression in PD-1-deficient
animals.
In summary, our findings indicate that, in sharp contrast with
other microorganisms that cause chronic infection, infection of
PD-1-deficient mice with M. tb causes increased inflammation and
bacterial load. Furthermore, we found an indirect role of reduced
autophagy for the increased bacterial burden in PD-1
2/2 mice.
These findings therefore suggest a protective role of the PD-1/PD-
L pathway in host immunity against M. tb. Manipulation of this
pathway in patients infected with M. tb or co-infected with M. tb
and HIV could therefore lead to unexpected outcomes.
Figure 5. Enhanced Th1, Th2 and Th17 cytokines in PD-1
2/2 mice infected with M. tb. Th1, Th2 and Th17 cytokines were assayed in the
supernatant with luminex at (A) 48 hours and (B) 72 hours following activation of T lymphocytes by H37Rv protein lysate in the presence of
mitomycin C-treated splenocytes. Data shown here is a representative experiment of three. (C) All cytokines in serum were present at higher amounts
in PD-1
2/2 mice compared with WT mice. Samples were collected at particular time points (days) after infection with M. tb. Data shown here is a
representative experiment of two. At each time point three mice were used.
doi:10.1371/journal.pone.0019864.g005
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Ethics Statement
All animal experiments were conducted in accordance with
guidelines approved by the Institutional Animals Ethics Commit-
tee meeting held on 22
nd November 2007 at ICGEB (approval ID;
ICGEB/IAEC/IMM-13/2007), New Delhi, India and Depart-
ment of Biotechnology (DBT) guidelines, Government of India. At
the relevant times after infection with M. tb, all mice were
humanely killed by asphyxiation in carbon dioxide according to
institutional and DBT regulations.
Mice
C57BL/6 and PD-1 deficient mice (obtained from Dr. Tasuku
Honjo, Yoshida-konoe, Sakyo-ku, Kyoto University, Japan, via
Dr. Megan Sikes, Transplantation Biology Research Center,
Harvard Medical School, Boston, MA, USA) on a C57BL/6
background were bred in our specific pathogen-free animal facility
at International Centre for Genetic Engineering and Biotechnol-
ogy (ICGEB), New Delhi, India. PD-1
2/2 mice were crossed with
Foxp3
gfp knock-in mice to obtain the PD-1
2/2 Foxp3
gfp mice.
Mice were housed under barrier conditions in a basic safely level
III laboratory.
Antibodies and Reagents
We used the following antibodies: anti-CD4 (clone: GK1.5)-
FITC, -PerCP-Cy5 or -APC, anti-CD3 (clone: 145-2C11)-PerCP-
Cy5, anti-CD19 (clone: MB19-1)-PE, SCA-1 (clone: D7)-FITC,
anti-IFN-c (clone: XMG1.2)-FITC, anti-IL-17 (clone: 17B7)-PE,
anti-CD25 (clone: PC61.5)-FITC, anti-PD-1 (clone: J43)-PE
antibodies (all from eBiosciences, USA), anti-CD8 (clone: 142
(53-6.7)), anti-CD44 (clone: IM7), anti-IL-4 (clone: 8D4-8) (all
from BD pharmingen
TM, USA), anti-LC3-B (clone: Ab-2775S)
(Cell signalling, USA), and IgG-Fab2 (Clone: 4412) (Cell
signalling, USA).
Flow cytometry: surface and intracellular staining
Spleens were isolated from PD-1
2/2 and WT mice, either
infected or uninfected, and macerated by frosted slides in 10%
RPMI 1640 (Gibco, Invitrogen, UK) and made into a single cell
suspension. Red blood cells (RBCs) were lysed with RBC cell lysis
buffer, incubated at room temperature for three to five minutes
and washed with 10% RPMI 1460. The cells were counted and
1610
6 cells were used for surface staining. For intracellular
staining 1610
6 cells were cultured per well in 24 well plates (Nunc,
USA) and activated with 50 ng/ml phorbol 12-myristate 13-
acetate (PMA) and 750 ng/ml ionomycin (Sigma, USA) overnight,
and 10 mg/ml brefeldin A (eBiosciences, USA) was added during
the last 4 hours of culture. Cells were washed twice with PBS and
stained with antibodies directed against surface markers. After
staining, cells were washed again with PBS and cells were fixed
with 100 ml fixation buffer (eBiociences, USA) for 30 minutes, then
re-suspended in 200 ml permeabilization buffer (eBiosciences,
USA) and stained with fluorescently labelled anti-cytokine
antibodies. Fluorescence intensity of fluorochrome-labelled cells
was measured by flow cytometry (FACS Canto
TM II, BD
Biosciences, USA). LC3-B staining was performed according to
the manufacturer’s protocol (Cell Signalling, USA) and cell
viability dye (7-AAD) was added to the LC3-B stained cells 15
minutes before analyzing the cells by flow cytometry. FACS Diva
was used for acquiring the cells and final data analysis was
performed by Flow Jo (Tree star, USA).
T and B cell proliferation assay
Spleens were isolated from PD-1
2/2 and WT mice, either
infected or uninfected, and macerated by frosted slides in 10%
RPMI 1640 (Gibco, Invitrogen, UK) and made into a single cell
suspension. Red blood cells (RBCs) were lysed with RBC cell lysis
buffer and incubated at room temperature for three to five minutes
and washed with 10% RPMI 1460. The total splenocytes were
passed through nylon wool columns as described earlier to isolate
T lymphocytes [45] and B cells were isolated using CD19
+
magnetic beads and a B cell isolation kit using the manufacturer’s
instructions (Miltenyi Biotech, Germany). Similarly, lung T
lymphocytes were isolated by nylon wool column method. T
lymphocytes were counted and plated at 0.3610
6 cells/well in a
96-well plate together with equal numbers of mitomycin C (Sigma,
USA) treated syngeneic splenocytes as APCs and stimulated with
different concentrations of H37Rv bacterial protein lysate or M. tb
complete soluble protein (CSA). B cells were activated with LPS
(Sigma, USA) at various concentrations for B cell proliferation.-
Cells were cultured for 48 hours and then pulsed with tritiated
thymidine (3H-TdR, 1.0 mCi per well; Amersham Biosciences,
Figure 6. Cytokine storm in M. tb infected PD-1
2/2 mice. Lung tissues and spleens were homogenised and passed through nylon wool
columns. The isolated T lymphocytes were co-cultured in the presence of mitomycin C-treated syngeneic splenocytes and H37Rv protein lysate
overnight in the presence of PMA and Ionomycin. The next day cells were treated with brefeldin A for four hours. Next, cells were surface stained with
anti-CD4 and anti-CD8, and fixed cells were used for intracellular staining with anti-IL-4, anti-IFN-c and anti-IL-17A antibodies. Cells were acquired on
a flow cytometer. A. Total IL-4, IFN-c and IL-17 production by lung or spleen mononuclear cells from WT and PD-1-deficient mice is shown by flow
cytometry in dot plots. Data shown here is a representative experiment of three. B. Summary of the data for IL-4, IFN-c and IL-17 production.
Summary statistics show mean6STDEV and Student’s t-test was applied for estimating significance between two parameters.
doi:10.1371/journal.pone.0019864.g006
Figure 7. PD-1
2/2 mice express reduced markers of autophagy
after M. tb infection. Macrophages were isolated from the
peritoneum of WT and PD-1
2/2 mice. Peritoneal macrophages were
stained with surface markers anti-CD11b and anti-CD11c and surface
stained cells were intracellularly stained for the LC3-B autophagy
marker. Cell viability dye 7-AAD was added before acquisition of cells by
flow cytometry. Peritoneal macrophage cells were gated for CD11b and
CD11c to analyze the expression of LC3-B and 7-AAD. Data shown here
are representative of two experiments.
doi:10.1371/journal.pone.0019864.g007
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cell harvester and liquid scintillation counter 16 hours later
(Wallac Trilux, Perkin Elmer, UK).
M. tb aerosol infection and colony forming unit (CFU)
estimation
M. tb strain H37Rv (ATCC 27294; American Type Culture
Collection, Rockville, MD) [46] infections were performed by
aerosol challenge. M. tb strain H37Rv was grown to mid-log phase
(OD600 ,0.6) in Middlebrook 7H9 media (Difco
TM, USA) with
0.1% Tween 80 (Sigma, USA), 0.2% glycerol and 10%
Middlebrook albumin, dextrose and catalase (ADC) enrichment
medium (Difco
TM, USA). Bacteria were stored at 280uC in 20%
glycerol stocks for further experiments. For aerosol infection,
cultured stock was washed with phosphate buffer saline (PBS)
twice and made into single cell suspensions. Mice were infected
with ,125 CFU of M. tb H37Rv using an aerosol chamber. Mice
were sacrificed at various time points and organs were harvested,
homogenised in 0.2 mm filtered PBS containing 0.05% Tween 80
and plated onto 7H11 Middlebrook (Difco
TM USA) plates
containing 10% oleic acid, albumin, dextrose and catalase
(OADC) (Difco
TM USA). Undiluted, ten-fold diluted and one
hundred-fold diluted lung and spleen cell homogenates were
plated in doublet on the above 7H11 plates and incubated at 37uC
for 21 days. Colonies were counted and CFU were estimated.
Cytokine assay
Th1, Th2 and Th17 serum cytokines were assayed by a
Luminex microbead-based multiplexed (Qiagen Luminex Liqui-
chip, USA) assay using commercially available kits according to
the manufacturer’s protocol (BioPlex, Bio-Rad).
Histology staining
Lung tissues were stained with Acid Fast Bacilli (AFB) stain and
Hematoxylin and Eosin (H&E) dyes as previously described [47].
Statistical analysis
All data were analyzed by Excel 2007. In all the figures mean
values were calculated with standard deviation (STDEV) until
unless stated otherwise. For all statistical analyses Student’s t-test
was performed to compare two groups, p,0.05 was considered
significant.
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